Trial Profile
Prospective Randomized Placebo Controlled Blinded Study to Evaluate the Efficacy of Alfuzosin (Alpha Blocker) on the Success Rates Following SWL.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Feb 2017
Price :
$35
*
At a glance
- Drugs Alfuzosin (Primary)
- Indications Renal calculi; Ureteral calculi; Urolithiasis
- Focus Adverse reactions; Therapeutic Use
- 28 Feb 2017 New trial record